vemurafenib

5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!"
Motley Fool
Sun, 07/5/15 - 11:03 am
Exelixis
Cobimetinib
vemurafenib
Cometriq
GSK's phase III study of trametinib and dabrafenib combo shows survival benefit compared to vemurafenib
Pharmabiz
Sat, 07/19/14 - 09:20 am
trametinib
GSK
vemurafenib
dabrafenib
melanoma
Roche licenses vemurafenib to Chugai
Pharmaceutical Business Review
Mon, 08/15/11 - 12:25 pm
Roche
vemurafenib
Chugai
melanoma
BRAF inhibitor
Weekend at ASCO: Drugs for Skin, Lung, Ovarian Cancer
WSJ Online
Mon, 06/6/11 - 09:27 pm
ASCO
melanoma
ovarian cancer
lung cancer
Pfizer
crizotinib
vemurafenib
JNJ
prostate cancer
Roche
Avastin
Zytiga
Roche's vemurafenib plays a starring role at ASCO
Fierce Biotech
Mon, 06/6/11 - 09:36 am
Roche
ASCO
vemurafenib
Plexxikon
melanoma
Roche, Bristol Melanoma Drugs Shine
The Street
Sun, 06/5/11 - 10:39 am
Roche
Bristol-Myers Squibb
melanoma
vemurafenib
Yervoy
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Wed, 05/25/11 - 09:28 am
Roche
skin cancer
melanoma
vemurafenib
GSK
Bristol-Myers Squibb
Daiichi Sankyo
Yervoy
Roche seeks approvals for new skin cancer drug
Reuters
Wed, 05/11/11 - 10:32 am
Roche
skin cancer
vemurafenib